The usefulness of a panel of immunostains in the diagnosis and differentiation of metastatic malignancies in pericardial effusions

Cytopathology

Volumn 11, Issue 5, 2000, Pages 312-321

  Gupta, R K ^a   Kenwright, D N ^a   Fauck, R ^a   Lallu, S ^a   Naran, S ^a  

^a WELLINGTON HOSPITAL   (New Zealand)

Author keywords

Immunostains; Metastatic malignancies; Pericardial effusion

Indexed keywords

ANTIBODY; CARCINOEMBRYONIC ANTIGEN; CD45 ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MONOCLONAL ANTIBODY B.72.3; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; VIMENTIN;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; NONHODGKIN LYMPHOMA; PERICARDIAL EFFUSION; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PERICARDIAL EFFUSION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0033829646     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2000.00260.x     Document Type: Article

References (22)

1. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy
2. Value of immunocytochemistry in the study of malignant effusions
3. Flow cytometric analysis and cytopatholgy of body cavity fluids
4. Measurment of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions
5. Diagnosis of pleural effusions by chromosome analysis
6. Chromosome analysis and cell cytology in effusions: A comparative study
7. The integration of cytogenetic analysis into the evaluation of cryptic exudative effusions
8. Immunocytochemistry applied to cytologic specimens
9. Differential diagnosis between mesothelioma and adenocarcinoma: A multimodal approach based on ultrastructure and immunocytochemistry
10. The use of immunoperoxidase panels for the Cytologic diagnosis of malignancy in serous effusions
11. Pleural, peritoneal and pericardial fluids
12. Malignant pericardial effusions as the initial presentation of malignancy
13. The immunohistochemical diagnostic panel for epithelial mesothelioma: A re-evaluation after heat-induced epitope retrieval
14. The value of anti-calretinin antibody in the differential diagnosis of normal and reactive hyperplasia versus metastatic tumours in effusion
15. E-cadherin, N-cadherin and calretinin in pleural effusions: The good, the bad, the worthless
16. Detection of cancer cells in effusions from patients diagnosed with gynecological malignacies. Evaluation of five epithelial markers
17. MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells
18. The role of conventional cytology, immunocytochemistry and flow cytometric DNA ploidy in the evaluation of body cavity fluids: A prospective study of 52 patients
19. Reactive mesothelial hyperplasia vs mesothelioma including mesothelioma in situ
20. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses
21. Malignant mesothelioma eight years after diagnosis of atypical mesothelial hyperplasia